Tech Company Financing Transactions
diaDexus Funding Round
On 2/9/2009, diaDexus secured $9.2 million in Series F funding from Baker Brothers Investments, GlaxoSmithKline and Scale Venture Partners.
Transaction Overview
Company Name
Announced On
2/9/2009
Transaction Type
Venture Equity
Amount
$9,200,000
Round
Series F
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
343 Oyster Point Boulevard
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
diaDexus was formed in 1997 as a joint venture by SmithKline Beecham and Incyte. SmithKline Beecham granted diaDexus an exclusive license to certain diagnostic intellectual property, and Incyte contributed free access to its databases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Plewman
Chief Financial Officer
David Foster
Executive Vice President
Robert Wolfert
Browse more venture capital transactions:
Prev: 2/9/2009: InboundWriter venture capital transaction
Next: 2/9/2009: M-Factor venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs